Key Takeaways Celsius targets the health-conscious and fitness-focused enthusiasts with sugar-free, functional drinks.Monster Beverage offers a variety of beverages, including energy drinks, iced teas and alcoholic options.Both the companies develop their portfolios to resonate well with the demand for healthier beverages. Celsius Holdings, Inc. (CELH) and Monster Beverage Corporation (MNST) stand out as two leading forces in the beverage industry, particularly in the energy and functional market. While Cel ...

Core Insights - Monster Beverage Corporation reported strong second-quarter 2025 earnings, with adjusted earnings per share of 52 cents, surpassing the Zacks Consensus Estimate of 48 cents, and reflecting a 23% year-over-year increase [3][12] - Net sales reached $2.11 billion, exceeding the Zacks Consensus Estimate of $2.08 billion, marking an 11.1% year-over-year growth [3][12] Sales Performance - The company experienced growth in household penetration and per capita consumption, driven by robust demand for energy drinks and product innovation [2] - In the United States, the Monster Energy Ultra Blue Hawaiian was a top-selling product, contributing to an 8.6% year-over-year increase in net sales in the US and Canada [10] - Internationally, net sales outside the United States rose 15.8% to $864.2 million, accounting for approximately 41% of total net sales [11] Segment Analysis - The Monster Energy Drinks segment saw sales increase by 11.2% to $1.94 billion, with a currency-adjusted growth of 11.4% [13] - Strategic Brands, which includes affordable energy brands like Predator and Fury, reported a 18.9% year-over-year increase in net sales to $129.9 million [14] - The Alcohol Brands segment experienced a decline, with net sales dropping 8.6% year over year to $38 million [15] Cost and Margin Insights - The cost of sales increased by 6.1% year over year to $935.2 million, while gross margin expanded by 210 basis points to 55.7% due to pricing and supply-chain optimization [16] - Adjusted operating expenses rose 8.4% to $497.7 million, with a slight decline in the percentage of net sales [17] Financial Health - As of the end of the second quarter 2025, the company had cash and cash equivalents of $1.93 billion and total stockholders' equity of $7.19 billion [19] - The company did not repurchase any shares during the reported quarter, with approximately $500 million available for buyback under its existing program [19]

Core Insights - Monster Beverage Corporation's fourth-quarter 2024 results showed adjusted earnings of 38 cents per share, missing the Zacks Consensus Estimate of 40 cents, and remaining flat year over year [2] - Net sales reached $1.81 billion, exceeding the Zacks Consensus Estimate of $1.79 billion, with a year-over-year growth of 4.7% [2] Financial Performance - Adjusted earnings missed expectations, while net sales grew, indicating a mixed financial performance [2] - The company faced a negative impact of $52.3 million from unfavorable currency translations, but net sales increased by 7.8% on a currency-adjusted basis [2] - The cost of sales was $809.6 million, up 2.3% year over year, with gross margin expanding by 110 basis points to 55.3% [13] Segment Performance - Sales of Monster Energy drinks rose 4.5% to $1.67 billion, with a negative impact of $49 million from currency rates [10] - Strategic Brands segment saw an 11.1% increase in net sales to $102 million, with a currency-adjusted growth of 14.7% [11] - Alcohol Brands segment experienced a decline of 0.8% in net sales to $34.9 million due to soft sales volume [12] Market Trends - The energy drink category in the U.S. showed sustained growth, with increased household purchases and per-person consumption [5] - Internationally, net sales outside the U.S. rose 11.7% to $711.5 million, accounting for approximately 39.3% of total net sales [9] - The Latin American market exhibited the highest growth at 20.2%, while EMEA and APAC regions grew by 14.4% and 11.8%, respectively [9][8] Cost and Margin Analysis - Adjusted operating expenses increased by 5.5% year over year to $488.7 million, influenced by higher impairment charges and payroll expenses [14] - Selling expenses as a percentage of net sales rose to 10.7%, while distribution costs decreased to 4.3% [15] Financial Health - The company ended 2024 with cash and cash equivalents of $1.5 billion and total stockholders' equity of $6 billion [16] - No share repurchases were made in the fourth quarter, with approximately $500 million available for buyback under the existing program [16]